Company intelligence / Profile preview

福建大谱生物医药

Fuzhou, Fujian, China

Ownership: Private
Development stage: Other

Overview

Dapu Bio is a high-tech enterprise specializing in the application of clinical proteomics and mass spectrometry for precision medicine. The company has developed a proprietary high-throughput proteomics platform that enables the discovery and validation of novel biomarkers for early disease screening and companion diagnostics. Dapu Bio provides comprehensive solutions including clinical mass spectrometry reagents, diagnostic kits, and CRO services for pharmaceutical companies. Their business model focuses on bridging the gap between advanced proteomic research and routine clinical application, particularly in oncology and chronic disease management.

Therapeutic areas: CardiovascularMetabolic DisordersOncology
Modalities: BiologicProteinDiagnostic kit
Industry: Protein Biomarker Diagnostics

Partnerships

Thermo Fisher Scientific

Beyond the preview

Go deeper on 福建大谱生物医药.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 福建大谱生物医药.

Explore the full profile